Xtant Medical Holdings, Inc. (XTNT) research
Xtant Medical Holdings, Inc.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.35
- As of
Xtant Medical Holdings, Inc. (XTNT): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-11.
As of . Source: SEC EDGAR filings for XTNT. Method and limitations.
Share the XTNT intelligence card
See XTNT live in the terminal
Track XTNT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live XTNT terminal, freeActive signals for XTNT
- lowEARNINGS_BEAT
Q3-2025: EPS $0.01 vs $-0.0051 estimate, +0.02 on a near-zero consensus
- lowEARNINGS_MISS
Q1-2026: EPS $-0.02 vs $-0.017 estimate, in line on a near-zero consensus
- lowEARNINGS_BEAT
Q2-2025: EPS $0.02 vs $-0.0102 estimate, +0.03 on a near-zero consensus
- lowEARNINGS_BEAT
Q4-2025: EPS $0.01 vs $-0.0051 estimate, +0.02 on a near-zero consensus
- lowEARNINGS_BEAT
Q4-2025: EPS $0.00 vs $-0.0051 estimate, +0.01 on a near-zero consensus
FREE, NO ACCOUNT
Every signal on XTNT, as it fires
You are seeing 5 of 6 signals recorded on XTNT since 2026-05-17.
The five above landed across 2 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in XTNT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 98420P308 · 2026Q2 | $394K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 98420P308 · 2026Q2 | $81K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 98420P308 · 2026Q2 | $36K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, XTNT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
XTNT against its peers
XTNT's operating margin of 5.4% ranks in the 90th percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | XTNT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 134M USD | 19.6M USD | 94 | 23 |
| Gross margin | 62.9% | 52.7% | 57 | 19 |
| Operating margin | 5.4% | -113.7% | 90 | 23 |
| Net margin | 3.7% | -94.1% | 81 | 23 |
| Return on equity | 9.8% | -74.2% | 84 | 21 |
| P / E | 11.8x | n/a | n/a | 2 |
Peers (23): SRTS, QTI, PAVM, ELUT, MDAI, COCH, SNWV, RPID, NSPR, OM, TELA, MDNC, NNOX, POSC, NSYS, PETV, MYO, ZOMDF, FOFA, ARAY, CVRX, SERA, BDMD. Left out: TLTFF (no annual filing), RTGN (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (XTNT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more XTNT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to XTNTand get the insider, 13F, options, and confluence read in one view.